Search tool

This Thematic paper contains the results of a study that examined drug prevention interventions for minority ethnic populations in 29 European countries. A total of 33 interventions were reported to the study...

The national drug policy of Ireland comes under the spotlight in the second volume in the EMCDDA series of Drug policy profiles. Examining the evolution of Irish drug policy through four periods...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the agency's activities to a broad readership. In this issue: EU drug markets report highlights; new EU drug strategy endorsed; upcoming risk...

At the end of September 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance 5-(2-aminopropyl)indole (commonly known by the abbreviation ‘5-IT’), through a joint assessment. The two...

This is the first of the three annual work programmes required to implement the activities and commitments set out in the EMCDDA’s new strategy for the 2013–15 period. The central challenge for...

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...

This Thematic paper presents the key findings of the European Union’s research project on Driving Under the Influence of Drugs, Alcohol and Medicines, known as the DRUID project. The project looked at...

The objective of this analysis is to map the existing data collection forms in the European countries and assess their level of comparability and harmonisation with the European guidelines (TDI ver. 3.0).

The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in...

Summary: In this issue: EMCDDA Annual report 2012 highlights; Selected issues 2012; Wastewater analysis; Reitox academy on building national observatories; EMCDDA and academia; new EMCDDA studies available online.